Home Iza-bren (BL-B01D1) + Serplulimab Demonstrates Breakthrough Efficacy as First-Line Therapy for Extensive-Stage Small Cell Lung Cancer

Iza-bren (BL-B01D1) + Serplulimab Demonstrates Breakthrough Efficacy as First-Line Therapy for Extensive-Stage Small Cell Lung Cancer

May 25, 2026 00:00 CST Updated 01:41